Innovator’s Pitch Challenge

Vote for Us

Interested in Connecting? Please contact:
Kay Olmstead
CEO
kay@nanopharmasolutions.com

Message the company or request a 1:1 meeting here

A proprietary drug delivery nanotechnology that generates poorly soluble drugs as nanoparticles for better bioavailability. Our NanoTransformer(TM) technology can generate drug nanoparticles through phase transfer method without using any chemicals or solvent. We work with (1) preclinical stage drug developers for animal study formulations and (2) innovative generic companies for generic nanodrug development. We are at revenue stage and our revenue forecast is $150M in 2026 (our target exit time frame).

Pitch Video

Slide Deck